Your browser doesn't support javascript.
loading
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.
Moskowitz, Craig H; Walewski, Jan; Nademanee, Auayporn; Masszi, Tamas; Agura, Edward; Holowiecki, Jerzy; Abidi, Muneer H; Chen, Andy I; Stiff, Patrick; Viviani, Simonetta; Bachanova, Veronika; Sureda, Anna; McClendon, Teresa; Lee, Connie; Lisano, Julie; Sweetenham, John.
Afiliação
  • Moskowitz CH; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL.
  • Walewski J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw, Poland.
  • Nademanee A; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Masszi T; 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Agura E; Blood and Marrow Transplantation, Baylor University Medical Center, Dallas, TX.
  • Holowiecki J; Department of Bone Marrow Transplantation & Oncohematology, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland.
  • Abidi MH; Bone Marrow Transplant Program, Spectrum Health Cancer Center, Michigan State University, Grand Rapids, MI.
  • Chen AI; Center for Hematologic Malignancies, Oregon Health & Science University, Portland, OR.
  • Stiff P; Cardinal Bernardain Cancer Center, Loyola University Medical Center, Maywood, IL.
  • Viviani S; Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN.
  • Sureda A; Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia Hospitalet, Barcelona, Spain.
  • McClendon T; Seattle Genetics, Inc., Bothell, WA.
  • Lee C; Takeda Oncology, Cambridge, MA; and.
  • Lisano J; Seattle Genetics, Inc., Bothell, WA.
  • Sweetenham J; Department of Hematology and Blood and Marrow Transplant, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
Blood ; 132(25): 2639-2642, 2018 12 20.
Article em En | MEDLINE | ID: mdl-30266774
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados / Transplante de Células-Tronco Hematopoéticas Idioma: En Ano de publicação: 2018 Tipo de documento: Article